Portal de investigación
Dietary practices in isovaleric acidemia: A European survey.
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Pinto, A
- Daly, A
- Evans, S
- Almeida, MF
- Assoun, M
- Belanger-Quintana, A
- Bernabei, S
- Bollhalder, S
- Cassiman, D
- Champion, H
- Chan, H
- de Boer, F
- de Laet, C
- de Meyer, A
- Desloovere, A
- Dianin, A
- Dixon, M
- Dokoupil, K
- Dubois, S
- Eyskens, F
- Faria, A
- Fasan, I
- Favre, E
- Feillet, F
- Fekete, A
- Gallo, G
- Gingell, C
- Gribben, J
- Kaalund-Hansen, K
- Horst, N
- Jankowski, C
- Janssen-Regelink, R
- Jones, I
- Jouault, C
- Kahrs, GE
- Kok, IL
- Kowalik, A
- Laguerre, C
- Le Verge, S
- Lilje, R
- Maddalon, C
- Mayr, D
- Meyer, U
- Micciche, A
- Robert, M
- Rocha, JC
- Rogozinski, H
- Rohde, C
- Ross, K
- Saruggia, I
- Schlune, A
- Singleton, K
- Sjoqvist, E
- Stolen, LH
- Terry, A
- Timmer, C
- Tomlinson, L
- Tooke, A
- Vande Kerckhove, K
- van Dam, E
- van den Hurk, T
- van der Ploeg, L
- van Driessche, M
- van Rijn, M
- van Teeffelen-Heithoff, A
- van Wegberg, A
- Vasconcelos, C
- Vestergaard, H
- Webster, D
- White, FJ
- White, L
- Zweers, H
- MacDonald, A
Grupos
Abstract
BACKGROUND: In Europe, dietary management of isovaleric acidemia (IVA) may vary widely. There is limited collective information about dietetic management. AIM: To describe European practice regarding the dietary management of IVA, prior to the availability of the E-IMD IVA guidelines (E-IMD 2014). METHODS: A cross-sectional questionnaire was sent to all European dietitians who were either members of the Society for the Study of Inborn Errors of Metabolism Dietitians Group (SSIEM-DG) or whom had responded to previous questionnaires on dietetic practice (n = 53). The questionnaire comprised 27 questions about the dietary management of IVA. RESULTS: Information on 140 patients with IVA from 39 centres was reported. 133 patients (38 centres) were given a protein restricted diet. Leucine-free amino acid supplements (LFAA) were routinely used to supplement protein intake in 58% of centres. The median total protein intake prescribed achieved the WHO/FAO/UNU [2007] safe levels of protein intake in all age groups. Centres that prescribed LFAA had lower natural protein intakes in most age groups except 1 to 10 y. In contrast, when centres were not using LFAA, the median natural protein intake met WHO/FAO/UNU [2007] safe levels of protein intake in all age groups. Enteral tube feeding was rarely prescribed. CONCLUSIONS: This survey demonstrates wide differences in dietary practice in the management of IVA across European centres. It provides unique dietary data collectively representing European practices in IVA which can be used as a foundation to compare dietary management changes as a consequence of the first E-IMD IVA guidelines availability.
Datos de la publicación
- ISSN/ISSNe:
- 2214-4269, 2214-4269
- Tipo:
- Article
- Páginas:
- 16-22
- PubMed:
- 28275552
- Factor de Impacto:
- 0,523 SCImago ℠
- Cuartil:
- Q3 SCImago ℠
Molecular Genetics And Metabolism Reports ELSEVIER SCIENCE BV
Citas Recibidas en Web of Science: 14
Documentos
- No hay documentos
Filiaciones
Keywords
- Isovaleric acidemia; Leucine; Leucine free l-amino acids; Natural protein; Protein restricted diet
Proyectos y Estudios Clínicos
ESTUDIO POSTAUTORIZACIÓN DE SEGURIDAD (EPAS) NO INTERVENCIONAL PARA EVALUAR LA SEGURIDAD A LARGO PLAZO DEL TRATAMIENTO CON ORFADIN EN LA TIROSINEMIA HEREDITARIA TIPO 1 (TH-1) EN LA PRÁCTICA CLÍNICA ESTÁNDAR.
Investigador Principal: ISIDRO VITORIA MIÑANA
SWE-NIT-2013-01 . 2014
ESTUDIO OBSERVACIONAL, AMBISPECTIVO DE HISTORIA NATURAL EN PACIENTES CON MUCOPOLISACARIDOSIS TIPO IIIA (MPS IIIA) O SÍNDROME DE SANFILIPPO TIPO A.
Investigador Principal: ISIDRO VITORIA MIÑANA
EST-SFA-2013-01 . 2014
OPTIMIZACIÓN DE LAS TERAPIAS DE SUSTITUCIÓN ENZIMÁTICA EN PACIENTES CON ENFERMEDADES DE DEPÓSITO LISOSOMAL.
Investigador Principal: JOSÉ LUIS POVEDA ANDRÉS
JLP-ELO-2017-01
ESTUDIO DE RESULTADOS DE HUNTER: REGISTRO OBSERVACIONAL, INTERNACIONAL Y MULTICÉNTRICO A LARGO PLAZO DE PACIENTES CON SÍNDROME DE HUNTER (MUCOPOLISACARIDOSIS DE TIPO II, MPS II).
Investigador Principal: ISIDRO VITORIA MIÑANA
SHI-IDU-2011-01 . 2014
PROTOCOLO DEL REGISTRO DE LA ENFERMEDAD DE GAUCHER.
Investigador Principal: ISIDRO VITORIA MIÑANA
GEN-GAU-2013-01 . 2018
PROTOCOLO DE VIGILANCIA DEL E-HOD/CYSTADANE.
Investigador Principal: JAIME DALMAU SERRA
ORP-CYS-2014-01
MONITORIZACIÓN E INDIVIDUALIZACIÓN POSOLÓGICA DE GLUCOCEREBROSIDASA EN PACIENTES GAUCHER TIPO I.
Investigador Principal: ISIDRO VITORIA MIÑANA
FIS-IMI-2012-01
Cita
Pinto A,Daly A,Evans S,Almeida MF,Assoun M,Belanger A,Bernabei S,Bollhalder S,Cassiman D,Champion H,Chan H,DALMAU J,de Boer F,de Laet C,de Meyer A,Desloovere A,Dianin A,Dixon M,Dokoupil K,Dubois S,Eyskens F,Faria A,Fasan I,Favre E,Feillet F,Fekete A,Gallo G,Gingell C,Gribben J,Kaalund K,Horst N,Jankowski C,Janssen R,Jones I,Jouault C,Kahrs GE,Kok IL,Kowalik A,Laguerre C,Le S,Lilje R,Maddalon C,Mayr D,Meyer U,Micciche A,Robert M,Rocha JC,Rogozinski H,Rohde C,Ross K,Saruggia I,Schlune A,Singleton K,Sjoqvist E,Stolen LH,Terry A,Timmer C,Tomlinson L,Tooke A,Vande K,van E,van den Hurk T,van der Ploeg L,van M,van M,van Teeffelen A,van A,Vasconcelos C,Vestergaard H,VITORIA I,Webster D,White FJ,White L,Zweers H,MacDonald A. Dietary practices in isovaleric acidemia: A European survey. Mol Genet Metab Rep. 2017. 12. p. 16-22.